Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AC Immune (ACIU) Depreciation & Amortization - Total: 2019-2025

Historic Depreciation & Amortization - Total for AC Immune (ACIU) over the last 7 years, with Sep 2025 value amounting to $341,270.

  • AC Immune's Depreciation & Amortization - Total rose 73.93% to $341,270 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 55.23%. This contributed to the annual value of $557,023 for FY2021, which is 16.57% up from last year.
  • As of Q3 2025, AC Immune's Depreciation & Amortization - Total stood at $341,270, which was up 8.67% from $314,051 recorded in Q2 2025.
  • AC Immune's 5-year Depreciation & Amortization - Total high stood at $341,270 for Q3 2025, and its period low was $118,348 during Q1 2021.
  • Moreover, its 3-year median value for Depreciation & Amortization - Total was $191,329 (2024), whereas its average is $217,422.
  • Its Depreciation & Amortization - Total has fluctuated over the past 5 years, first fell by 4.43% in 2023, then surged by 73.93% in 2025.
  • Quarterly analysis of 5 years shows AC Immune's Depreciation & Amortization - Total stood at $153,999 in 2021, then decreased by 4.25% to $147,035 in 2022, then increased by 4.72% to $153,973 in 2023, then rose by 27.44% to $196,215 in 2024, then surged by 73.93% to $341,270 in 2025.
  • Its Depreciation & Amortization - Total stands at $341,270 for Q3 2025, versus $314,051 for Q2 2025 and $279,175 for Q1 2025.